Effectiveness of dose‐dense methotrexate, vinblastine, doxorubicin, and cisplatin as compared to gemcitabine‐based regimens as neoadjuvant chemotherapy for oncologic outcomes in muscle‐invasive bladder cancer cases—Single‐center study in Japan

Ähnliche Einträge

• Inflammatory Markers in Combination With Multiple Patterns of Extrarenal Extension Accurately Indicate Recurrence Risk in Patients With pT3aN0M0 Clear Cell Renal Cell Carcinoma
  von: Masato Uetani, et al.
  Veröffentlicht: (2025)
• Efficacy and safety of dose‐dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle‐invasive bladder cancer
  von: Yuto Hattori, et al.
  Veröffentlicht: (2024)
• Editorial Comment to “Causal relationship between folic acid and prostate cancer risk: Insights from Mendelian randomization analysis”
  von: Yozo Mitsui, et al.
  Veröffentlicht: (2024)
• Editorial Comment to “Efficacy and safety of dose‐dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle‐invasive bladder cancer”
  von: Eiji Kikuchi, et al.
  Veröffentlicht: (2024)
• Successful Combination Therapy With Lenvatinib Plus Pembrolizumab for Rare Case of Advanced Renal Cell Carcinoma With Ocular Adnexal Metastasis
  von: Yozo Mitsui, et al.
  Veröffentlicht: (2025)